Contents
Download PDF
pdf Download XML
398 Views
212 Downloads
Share this article
Research Article | Volume 11 Issue :4 (, 2021) | Pages 36 - 40
Efficacy of the herbal hepatoprotector in patients with coronary artery disease after PCI
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
Dec. 25, 2021
Abstract

Coronary artery disease (CAD) is leading due to disability and death of the working population, and successful its treatment is largely determined by maintaining adequate coronary blood flow, including through interventions, percutaneous interventions. This article describes the efficacy of the adding herbal hepatoprotector - Hepofresh 2 tablets 3 times a day on the framework of the standard therapy on some indicators of the functional state of the liver of patients with coronary heart disease with stable angina of III-IV FC, subjected to percutaneous intervention (PCI). And the results show that Hepofresh contributes to better tolerance of treatment, increases its effectiveness and prevent the development of side effects and various liver disorders in patients CAD after PCI.

Keywords
Recommended Articles
Case Report
Anterior Cerebral Artery Territory Infarcts Presenting as Isolated Lower Limb Monoparesis: A Case Series
...
Published: 03/10/2025
Download PDF
Research Article
Clinico Epidemiological Study on Bronchogenic Carcinoma: A Hospital-Based Study from South India
...
Published: 03/10/2025
Download PDF
Research Article
Study of Psychosexual Behaviour of Postmenopausal Women Attending Menopause Clinic at KIMS, Amalapuram
...
Published: 28/09/2025
Download PDF
Case Report
Rhino-Orbital Mucormycosis and Perioperative Challenges in a Diabetic, Immunocompromised Patient with Raynaud’s Phenomenon Undergoing Staging Laparotomy
...
Published: 10/03/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.